enVVeno Medical Corporation
NVNO
$0.39
-$0.01-1.81%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.59M | 3.23M | 2.40M | 3.19M | 3.31M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.17M | 6.12M | 4.95M | 6.70M | 6.17M |
| Operating Income | -5.17M | -6.12M | -4.95M | -6.70M | -6.17M |
| Income Before Tax | -4.54M | -6.69M | -4.50M | -6.23M | -5.64M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.54M | -6.69M | -4.50M | -6.23M | -5.64M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.54M | -6.69M | -4.50M | -6.23M | -5.64M |
| EBIT | -5.17M | -6.12M | -4.95M | -6.70M | -6.17M |
| EBITDA | -5.14M | -6.09M | -4.91M | -6.66M | -6.13M |
| EPS Basic | -0.23 | -0.33 | -0.22 | -0.31 | -0.35 |
| Normalized Basic EPS | -0.16 | -0.18 | -0.15 | -0.20 | -0.24 |
| EPS Diluted | -0.23 | -0.33 | -0.22 | -0.31 | -0.35 |
| Normalized Diluted EPS | -0.16 | -0.18 | -0.15 | -0.20 | -0.24 |
| Average Basic Shares Outstanding | 20.16M | 20.35M | 20.35M | 20.38M | 16.07M |
| Average Diluted Shares Outstanding | 20.16M | 20.35M | 20.35M | 20.38M | 16.07M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |